Skip to content

Med Care Nursing: what changed

What changed

Med Care Nursing

BE 0685.993.601
NACE 86.940, Nursing and midwifery
filed annual accounts (NBB)
Financial years compared with
Net result for the year
€28,250
2023 · -€11,930+€40,181
Equity
€94,800
2023 · €66,550+€28,250
Cash
€202,016
2023 · €43,706+€158,310
Balance sheet total
€220,886
2023 · €66,550+€154,337

Largest movements

2023 to 2024
Assets
  • Cash +€158,310

    up €158,310 (+362%), from €43,706 to €202,016

    mainly Trade debts (+€68,225) and Other debts (+€57,861)

  • Receivables within one year -€3,938

    down €3,938 (-17.3%), from €22,808 to €18,870

    of which Other amounts receivable: -€18,998

Equity and liabilities
  • Trade debts +€68,225

    new in 2024: €68,225

  • Other debts +€57,861

    new in 2024: €57,861

  • Profit (loss) carried forward +€28,250

    up €28,250 (+46.0%), from €61,397 to €89,647

Income statement
  • Gross operating margin +€58,859

    up €58,859, from -€11,264 to €47,594

  • Staff costs +€16,391

    new in 2024: €16,391

  • Other operating charges +€2,210

    up €2,210 (+368%), from €600 to €2,811

Change in the result, 2023 to 2024

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2023 -€11,930
Gross operating margin +€58,859
Staff costs -€16,391
Other operating charges -€2,210
Financial charges -€76
Result 2024 €28,250
raises the resultlowers the result

Derived cash bridge

cash 2023 to 2024

The bridge is derived from the 2023 and 2024 balance sheets and the 2024 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€158,310
Investment €0
Financing €0
Cash 2023 €43,706
Net result for the year +€28,250
Receivables within one year +€3,938
Deferred charges and accrued income +€36
Trade debts +€68,225
Other debts +€57,861
Cash 2024 €202,016
brings cash in
Every line side by side 27 lines
Line Code 2023 2024 Change %
Total assets 20/58 €66,550 €220,886 +€154,337 +232%
Current assets 29/58 €66,550 €220,886 +€154,337 +232%
Amounts receivable within one year 40/41 €22,808 €18,870 -€3,938 -17.3%
Trade receivables 40 €3,810 €18,870 +€15,060 +395%
Other amounts receivable 41 €18,998 - -€18,998
Cash at bank and in hand 54/58 €43,706 €202,016 +€158,310 +362%
Deferred charges and accrued income 490/1 €36 - -€36
Total equity and liabilities 10/49 €66,550 €220,886 +€154,337 +232%
Equity 10/15 €66,550 €94,800 +€28,250 +42.5%
Contributions 10/11 €2,685 €2,685 = 0.0%
Reserves 13 €2,468 €2,468 = 0.0%
Distributable reserves 133 €2,468 €2,468 = 0.0%
Profit (loss) carried forward 14 €61,397 €89,647 +€28,250 +46.0%
Amounts payable 17/49 - €126,086 +€126,086
Amounts payable within one year 42/48 - €126,086 +€126,086
Trade debts 44 - €68,225 +€68,225
Suppliers 440/4 - €68,225 +€68,225
Other amounts payable 47/48 - €57,861 +€57,861
Remuneration, social security and pensions 62 - €16,391 +€16,391
Other operating charges 640/8 €600 €2,811 +€2,210 +368%
Gross operating margin 9900 -€11,264 €47,594 +€58,859
Operating profit (loss) 9901 -€11,865 €28,392 +€40,257
Financial charges 65/66B €65 €142 +€76 +117%
Recurring financial charges 65 €65 €142 +€76 +117%
Profit (loss) for the period before taxes 9903 -€11,930 €28,250 +€40,181
Profit (loss) for the period 9904 -€11,930 €28,250 +€40,181
Profit (loss) for the period to be appropriated 9905 -€11,930 €28,250 +€40,181
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Green is a favourable move for that line, red an unfavourable one. Prepared on 8 November 2026 via checked.be.